Komori
Fukuda Denshi (6960) · RiskMaterialised

Market Price Volatility Risk Affecting Securities and Investment Securities

First written in FY2017. 9 of 21 entries say "Materialised", first in FY2019. Latest entry: FY2026.

21entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2018MitigatedFY2022-Q1 – FY2022MitigatedFY2024-Q2 – FY20252017: 120172018: 120182019: 120192020: 320202021: 420212022: 320222023: 320232024: 220242025: 120252026: 22026
Same theme, other companies
Valuation Losses Due to Declines in the Market Value of Securities HeldA theme 226 companies write about · 223 as a headwind · 3 as a tailwind

Fukuda Denshi moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.

39 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MaterialisedAnnual report

    「During the fiscal year, the Company recognized an impairment loss of ¥343 million on securities, comprising ¥343 million on unlisted shares.」

    In connection with fluctuations in the market prices of securities and investment securities, an impairment loss of ¥343 million was actually recognized, up from ¥14 million in the previous fiscal year.
  2. 2026-05-15WorsenedRevision of earnings forecasts

    「Losses on valuation of investment securities 14 343」

    Losses on valuation of investment securities increased from ¥14 million in the previous fiscal year to ¥343 million.
  3. FY2025MitigatedAnnual report

    「During the fiscal year, the Company recognized an impairment loss of ¥14 million on securities, comprising ¥14 million on shares in affiliated companies.」

    Although an impairment loss on securities was recognized, it decreased from ¥29 million in the previous fiscal year to ¥14 million.
  4. FY2024MitigatedAnnual report

    「During the fiscal year, the Company recognized an impairment loss of ¥29 million on securities, comprising ¥29 million on shares in affiliated companies.」

    Although an impairment loss on securities was recognized, it decreased from ¥45 million in the previous fiscal year to ¥29 million.
  5. FY2024-Q3MitigatedAnnual report

    「Impairment loss on investment securities 53 26」

    The impairment loss on investment securities during the cumulative third quarter was ¥26 million, down from ¥53 million in the same period of the previous year.
  6. FY2024-Q2MitigatedAnnual report

    「Impairment loss on investment securities ¥48 million -」

    The impairment loss on investment securities of ¥48 million recognized in the same period of the previous year did not occur during the cumulative second quarter.
  7. FY2023MaterialisedAnnual report

    「During the fiscal year, the Company recognized an impairment loss of ¥45 million on securities, comprising ¥45 million on shares classified as other securities.」

    An impairment loss on securities of ¥45 million, which had not occurred in the previous fiscal year, was recognized.
  8. FY2023-Q3MaterialisedAnnual report

    「Impairment loss on investment securities — 53」

    The Company recognized an impairment loss on investment securities of ¥53 million during the cumulative third quarter, which had not occurred in the same period of the previous year, resulting in an actual loss from fluctuations in market prices.
  9. FY2023-Q2MaterialisedAnnual report

    「Impairment loss on investment securities 153 48」

    The Company recognized an impairment loss on investment securities of ¥48 million during the cumulative second quarter, resulting in an actual loss from fluctuations in market prices. This was down from ¥153 million in the same period of the previous year.
  10. FY2022MitigatedAnnual report

    「No impairment loss was recognized during the fiscal year.」

    After recognizing an impairment loss of ¥411 million on securities in the previous fiscal year, no impairment loss on securities was recognized during the current fiscal year.
  11. FY2022-Q3MitigatedAnnual report

    「Impairment loss on investment securities 399 —」

    The impairment loss on investment securities of ¥399 million recognized in the same period of the previous year did not occur during the cumulative third quarter.
  12. FY2022-Q2MitigatedAnnual report

    「Impairment loss on investment securities 381 153」

    The impairment loss on investment securities decreased from ¥381 million in the same period of the previous year to ¥153 million, reducing losses from fluctuations in market prices.
  13. FY2022-Q1MitigatedAnnual report

    「Impairment loss on investment securities 251 —」

    The impairment loss on investment securities of ¥251 million recognized in the same period of the previous year did not occur during the cumulative first quarter.
  14. FY2021MaterialisedAnnual report

    「During the fiscal year, the Company recognized an impairment loss of ¥411 million on securities, comprising ¥222 million on shares classified as other securities and ¥188 million on shares in subsidiaries.」

    In connection with the risk of fluctuations in the market prices of securities and investment securities, an impairment loss of ¥411 million was recognized during the fiscal year.
  15. FY2021-Q3MaterialisedAnnual report

    「Impairment loss on investment securities — 399」

    The Company recognized an impairment loss on investment securities of ¥399 million during the cumulative third quarter, which had not occurred in the same period of the previous year, meaning that losses from fluctuations in market prices continued to occur.
  16. FY2021-Q2MaterialisedAnnual report

    「Impairment loss on investment securities — 381」

    The Company recognized an impairment loss on investment securities of ¥381 million during the cumulative second quarter, which had not occurred during the cumulative second quarter of the previous year, resulting in another loss from fluctuations in market prices.
  17. FY2021-Q1MaterialisedAnnual report

    「Impairment loss on investment securities — 251」

    While no impairment loss on securities was recognized in the previous fiscal year, the Company recognized an impairment loss on investment securities of ¥251 million during the cumulative first quarter, resulting in another loss from fluctuations in market prices.
  18. FY2020MitigatedAnnual report

    「No impairment loss was recognized during the fiscal year.」

    After recognizing an impairment loss of ¥499 million on securities in the previous fiscal year, no impairment loss on securities was recognized during the current fiscal year.
  19. FY2019MaterialisedAnnual report

    「During the fiscal year, the Company recognized an impairment loss of ¥499 million on securities, comprising ¥499 million on shares classified as other securities.」

    An impairment loss of ¥499 million was actually recognized during the fiscal year in connection with the risk of fluctuations in the market prices of securities and investment securities.
  20. FY2018RestatedAnnual report

    「Securities and investment securities consist mainly of held-to-maturity bonds and shares in companies with which the Company has business relationships, and are exposed to the risk of fluctuations in market prices.」

    The risk of fluctuations in the market prices of securities and investment securities is reiterated. No impairment loss on investment securities was recognized during the fiscal year.
  21. FY2017First statedAnnual report

    「Securities and investment securities consist mainly of held-to-maturity bonds and shares in companies with which the Company has business relationships, and are exposed to the risk of fluctuations in market prices.」

    The risk of fluctuations in the market prices of securities and investment securities is recorded for the first time. The Company also recognized an impairment loss on investment securities of ¥147 million during the fiscal year.
Moved together

"Impairment Risk for Owned Assets" moved the same way as this thread, in the same document, in 9 of its 21 moves.

974322★123456
  1. ★This thread
  2. 1Impairment Risk for Owned Assets9×
  3. 2Foreign Exchange Risk from Foreign-Currency Transactions and Overseas Subsidiaries7×
  4. 3Strengthening the Community-Based Home Healthcare Network4×
  5. 4COVID-19 Prevention and Business Continuity Measures3×
  6. 5Impact on Performance from Uncertainty in Overseas Economies and Economic Downturns2×
  7. 6Nine-Month Revenue and Profit Growth2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Fukuda Denshi's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Revision of earnings forecasts of 2026-05-15: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Market Price Volatility Risk Affecting Securities and Investment Securities | FUKUDA DENSHI CO.,LTD. (6960) | Komori